PY
Pandurang Yashwant Kesarkar
About Pandurang Yashwant Kesarkar
Data last updated:
Pandurang Yashwant Kesarkar is a Director at Samarpan Pharmaceuticals Private Limited (since 2011) and Director at Shri Mahalsa-Ganesh Plantation Private Limited (since 2019). The companies operate in Pharma and Business Services. The largest current company by reported revenue is Samarpan Pharmaceuticals Private Limited at ₹1.61 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Samarpan Pharmaceuticals Private Limited U99999MH1990PTC059028 | Director | 25 Aug 2011 | 1990 | ₹1.61 Cr (FY 2024) | Active |
| Shri Mahalsa-Ganesh Plantation Private Limited U51101MH1997PTC105128 | Director | 10 Jul 2019 | 1997 | Active |
Board colleagues of Pandurang Yashwant Kesarkar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Smita Ravindra Shetiya | 01644747 | Samarpan Pharmaceuticals Private Limited , Shri Mahalsa-Ganesh Plantation Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pandurang Yashwant Kesarkar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pandurang Yashwant Kesarkar
Pandurang Yashwant Kesarkar currently holds 2 directorships: Samarpan Pharmaceuticals Private Limited (Director, since 25 Aug 2011, revenue ₹1.61 Cr (FY 2024)); Shri Mahalsa-Ganesh Plantation Private Limited (Director, since 10 Jul 2019).
Pandurang Yashwant Kesarkar was first appointed on 25 Aug 2011 as Director at Samarpan Pharmaceuticals Private Limited. The most recent appointment on record is 10 Jul 2019 at Shri Mahalsa-Ganesh Plantation Private Limited.
The current boards of Pandurang Yashwant Kesarkar's companies include Smita Ravindra Shetiya (Samarpan Pharmaceuticals Private Limited).